The combination of mesenchymal stem cells and a bone scaffold in the treatment of vertebral body defects

European Spine Journal

Volumn 22, Issue 12, 2013, Pages 2777-2786

  Vaněček, Václav ^a,b   Klíma, Karel ^b   Kohout, Aleš ^b   Foltán, René ^b   Jiroušek, Ondřej ^c   Šedý, Jiří ^d   Štulík, Jan ^e   Syková, Eva ^a,b   Jendelová, Pavla ^a,b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF THEORETICAL AND APPLIED MECHANICS   (Czech Republic)

^d INSTITUTE OF PHYSIOLOGY   (Czech Republic)

^e UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

Author keywords

Hydroxyapatite scaffold; Mesenchymal stem cells; Rat model; Vertebral body defect

Indexed keywords

GENTAMICIN; HYDROXYAPATITE; ISOFLURANE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BONE DEFECT; BONE IMPLANT; BONE REGENERATION; BONE TISSUE; COMPOSITE GRAFT; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; INFECTION PREVENTION; INFLAMMATION; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; VERTEBRA BODY; VERTEBRA MALFORMATION;

ANIMALS; BONE TRANSPLANTATION; DISEASE MODELS, ANIMAL; DURAPATITE; HUMANS; LUMBAR VERTEBRAE; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; RANDOM ALLOCATION; RATS; RATS, WISTAR; SPINAL INJURIES; TISSUE ENGINEERING; TISSUE SCAFFOLDS; WOUND HEALING;

EID: 84890558382     PISSN: 09406719     EISSN: 14320932     Source Type: Journal    
DOI: 10.1007/s00586-013-2991-2     Document Type: Article

References (41)

1. Barsa P (2012) Vertebroplasty - treatment options for structurally insufficient vertebras. Cesk Slov Neurol N 75:8-17
2. Sedy J, Urdzikova L, Jendelova P, Sykova E (2008) Methods for behavioral testing of spinal cord injured rats. Neurosci Biobehav Rev 32:550-580. doi: 10.1016/j.neubiorev.2007.10.001
3. Sykova E, Homola A, Mazanec R, Lachmann H, Konradova SL, Kobylka P, Padr R, Neuwirth J, Komrska V, Vavra V, Stulik J, Bojar M (2006) Autologous bone marrow transplantation in patients with subacute and chronic spinal cord injury. Cell Transpl 15:675-687
4. Wang Z, Lu B, Chen L, Chang J (2011) Evaluation of an osteostimulative putty in the sheep spine. J Mater Sci Mater Med 22:185-191. doi: 10.1007/s10856-010-4175-5
5. Bauer TW, Muschler GF (2000) Bone graft materials. An overview of the basic science. Clin Orthop Relat Res 371:10-27
6. Niu X, Feng Q, Wang M, Guo X, Zheng Q (2009) Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release 134:111-117. doi: 10.1016/j.jconrel.2008.11.020
7. Srouji S, Rachmiel A, Blumenfeld I, Livne E (2005) Mandibular defect repair by TGF-beta and IGF-1 released from a biodegradable osteoconductive hydrogel. J Craniomaxillofac Surg 33:79-84. doi: 10.1016/j.jcms.2004.09.003
8. Zhang M, Wang K, Shi Z, Yang H, Dang X, Wang W (2010) Osteogenesis of the construct combined BMSCs with beta-TCP in rat. J Plast Reconstr Aesthet Surg 63:227-232. doi: 10.1016/j.bjps.2008.11.017
9. Griffin M, Iqbal SA, Bayat A (2011) Exploring the application of mesenchymal stem cells in bone repair and regeneration. J Bone Joint Surg Br 93:427-434. doi: 10.1302/0301-620X.93B4.25249
10. Kim HJ, Park JB, Lee JK, Park EY, Park EA, Riew KD, Rhee SK (2008) Transplanted xenogenic bone marrow stem cells survive and generate new bone formation in the posterolateral lumbar spine of non-immunosuppressed rabbits. Eur Spine J 17:1515-1521. doi: 10.1007/s00586-008-0784-9
11. Kim J, Hematti P (2009) Mesenchymal stem cell-educated macrophages: a novel type of alternatively activated macrophages. Exp Hematol 37:1445-1453. doi: 10.1016/j.exphem.2009.09.004
12. Ghannam S, Bouffi C, Djouad F, Jorgensen C, Noel D (2010) Immunosuppression by mesenchymal stem cells: mechanisms and clinical applications. Stem Cell Res Therapy 1:2. doi: 10.1186/scrt2scrt2
13. Choi HJ, Kim JM, Kwon E, Che JH, Lee JI, Cho SR, Kang SK, Ra JC, Kang BC (2011) Establishment of efficacy and safety assessment of human adipose tissue-derived mesenchymal stem cells (hATMSCs) in a nude rat femoral segmental defect model. J Korean Med Sci 26:482-491. doi: 10.3346/jkms.2011.26.4.482
14. Huang JW, Lin SS, Chen LH, Liu SJ, Niu CC, Yuan LJ, Wu CC, Chen WJ (2011) The use of fluorescence-labeled mesenchymal stem cells in poly(lactide-co- glycolide)/hydroxyapatite/collagen hybrid graft as a bone substitute for posterolateral spinal fusion. J Trauma 70:1495-1502. doi: 10.1097/TA. 0b013e318216b9ee
15. Miura M, Miura Y, Sonoyama W, Yamaza T, Gronthos S, Shi S (2006) Bone marrow-derived mesenchymal stem cells for regenerative medicine in craniofacial region. Oral Dis 12:514-522. doi: 10.1111/j.1601-0825.2006.01300.x
16. Liang H, Wang K, Shimer AL, Li X, Balian G, Shen FH (2010) Use of a bioactive scaffold for the repair of bone defects in a novel reproducible vertebral body defect model. Bone 47:197-204. doi: 10.1016/j.bone.2010.05.023
17. Zhu XS, Zhang ZM, Mao HQ, Geng DC, Zou J, Wang GL, Zhang ZG, Wang JH, Chen L, Yang HL (2011) A novel sheep vertebral bone defect model for injectable bioactive vertebral augmentation materials. J Mater Sci Mater Med 22:159-164. doi: 10.1007/s10856-010-4191-5
18. Luize DS, Bosco AF, Bonfante S, de Almeida JM (2008) Influence of ovariectomy on healing of autogenous bone block grafts in the mandible: a histomorphometric study in an aged rat model. Int J Oral Maxillofac Implants 23:207-214
19. Turnovcova K, Ruzickova K, Vanecek V, Sykova E, Jendelova P (2009) Properties and growth of human bone marrow mesenchymal stromal cells cultivated in different media. Cytotherapy 11:874-885
20. Abdouh M, Facchino S, Chatoo W, Balasingam V, Ferreira J, Bernier G (2009) BMI1 sustains human glioblastoma multiforme stem cell renewal. J Neurosci 29:8884-8896
21. Amemori T, Romanyuk N, Jendelova P, Herynek V, Turnovcova K, Prochazka P, Kapcalova M, Cocks G, Price J, Sykova E (2013) Human conditionally immortalized neural stem cells improve locomotor function after spinal cord injury in the rat. Stem Cell Res Therapy 4:68
22. Cocks G, Romanyuk N, Amemori T, Jendelova P, Forostyak O, Jeffries AR, Perfect L, Thuret S, Dayanithi G, Sykova E, Price J (2013) Conditionally immortalized stem cell lines from human spinal cord retain regional identity and generate functional V2a interneurons and motorneurons. Stem Cell Res Therapy 4:69
23. Ruzicka J, Romanyuk N, Hejcl A, Vetrik M, Hruby M, Cocks G, Cihlar J, Pradny M, Price J, Sykova E, Jendelova P (2013) Treating spinal cord injury in rats with a combination of human fetal neural stem cells and hydrogels modified with serotonin. Acta Neurobiol Exp 73:102-115
24. Jakubek J, Holy T, Jakubek M, Vavrik D, Vykydal Z (2006) Experimental system for high resolution X-ray transmission radiography. Nucl Instr Methods Phys Res Sect A Accel Spectrom Detect Assoc Equip 563:278-281
25. Kytyr D, Jirousek O, Dammer J (2011) High resolution X-ray imaging of bone-implant interface by large area flat-panel detector. J Instrum 6:1-5
26. Vavrik D, Dammer J, Jakubek J, Jeon I, Jirousek O, Kroupa M, Zlamal P (2011) Advanced X-ray radiography and tomography in several engineering applications. Nucl Instr Methods Phys Res Sect A Accel Spectrom Detect Assoc Equip 633:S152-S155
27. Fujishiro T, Bauer TW, Kobayashi N, Kobayashi H, Sunwoo MH, Seim HB 3rd, Turner AS (2007) Histological evaluation of an impacted bone graft substitute composed of a combination of mineralized and demineralized allograft in a sheep vertebral bone defect. J Biomed Mater Res A 82:538-544. doi: 10.1002/jbm.a.31056
28. Kobayashi H, Fujishiro T, Belkoff SM, Kobayashi N, Turner AS, Seim HB 3rd, Zitelli J, Hawkins M, Bauer TW (2009) Long-term evaluation of a calcium phosphate bone cement with carboxymethyl cellulose in a vertebral defect model. J Biomed Mater Res A 88:880-888. doi: 10.1002/jbm.a.31933
29. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317. doi: 10.1080/ 14653240600855905
30. Nakajima T, Iizuka H, Tsutsumi S, Kayakabe M, Takagishi K (2007) Evaluation of posterolateral spinal fusion using mesenchymal stem cells: differences with or without osteogenic differentiation. Spine (Phila Pa 1976) 32:2432-2436. doi: 10.1097/BRS.0b013e3181573924
31. Zerbo IR, Bronckers AL, de Lange G, Burger EH (2005) Localisation of osteogenic and osteoclastic cells in porous beta-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomaterials 26:1445-1451. doi: 10.1016/j.biomaterials.2004.05.003
32. Boukhechba F, Balaguer T, Bouvet-Gerbettaz S, Michiels JF, Bouler JM, Carle GF, Scimeca JC, Rochet N (2011) Fate of bone marrow stromal cells in a syngenic model of bone formation. Tissue Eng Part A 17:2267-2278. doi: 10.1089/ten.TEA.2010.0461
33. Shapiro F (2008) Bone development and its relation to fracture repair. The role of mesenchymal osteoblasts and surface osteoblasts. Eur Cell Mater 15:53-76
34. Tortelli F, Tasso R, Loiacono F, Cancedda R (2010) The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. Biomaterials 31:242-249. doi: S0142-9612(09)00968-510.1016/j.biomaterials.2009.09.038
35. Baraniak PR, McDevitt TC (2010) Stem cell paracrine actions and tissue regeneration. Regen Med 5:121-143. doi: 10.2217/rme.09.74
36. Nauta AJ, Fibbe WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood 110:3499-3506. doi: 10.1182/blood-2007-02-069716
37. Hoogduijn MJ, Popp F, Verbeek R, Masoodi M, Nicolaou A, Baan C, Dahlke MH (2010) The immunomodulatory properties of mesenchymal stem cells and their use for immunotherapy. Int Immunopharmacol 10:1496-1500. doi: 10.1016/j.intimp.2010. 06.019
38. Le Blanc K, Rasmusson I, Gotherstrom C, Seidel C, Sundberg B, Sundin M, Rosendahl K, Tammik C, Ringden O (2004) Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin- activated lymphocytes. Scand J Immunol 60:307-315. doi: 10.1111/j.0300-9475. 2004.01483.x
39. Maccario R, Moretta A, Cometa A, Montagna D, Comoli P, Locatelli F, Podesta M, Frassoni F (2005) Human mesenchymal stem cells and cyclosporin a exert a synergistic suppressive effect on in vitro activation of alloantigen-specific cytotoxic lymphocytes. Biol Blood Marrow Transpl 11:1031-1032. doi: 10.1016/j.bbmt.2005.08.039
40. Tcacencu I, Karlstrom E, Cedervall J, Wendel M (2012) Transplanted human bone marrow mesenchymal stem cells seeded onto peptide hydrogel decrease alveolar bone loss. Biores Open Access 1:215-221. doi: 10.1089/biores.2012.0239
41. Centeno CJ, Schultz JR, Cheever M, Freeman M, Faulkner S, Robinson B, Hanson R (2011) Safety and complications reporting update on the re-implantation of culture-expanded mesenchymal stem cells using autologous platelet lysate technique. Curr Stem Cell Res Ther 6:368-378. doi: 10.2174/157488811797904371